HCKT

Hackett's income statement is on a clear multi-year slide that the market is not yet discounting. Net income has fallen every single year from $41.5M in FY2021 to $12.9M in FY2025 — a 56.3% collapse in the latest year alone — while revenue actually shrank 2.6% to $306M. Operating income dropped 47.2% to $23.5M and diluted EPS fell 56.2% to $0.46. This is not cyclical noise; it is a four-year compression in a management-consulting business whose MD&A concedes results are directly exposed to macro conditions, inflation and 'levels of business confidence.' At $10.84 the stock trades at 23.6x depressed earnings — a premium multiple on a shrinking profit stream, which is the opposite of what you want to pay for.

The balance sheet has been re-engineered in a way that flatters headline ratios while raising risk. Long-term debt exploded 495.4% to $75.8M and total liabilities jumped 78.0%, pushing liabilities/equity to 2.03x. Meanwhile the company spent $69.1M on buybacks (up 977%) and $12.9M on dividends — a combined $82M return of capital funded partly by leverage — which cut shares 8.7% and gutted stockholders' equity by 41.1% to $68.1M. The 19.0% ROE looks respectable only because the equity base was shrunk; on the underlying earnings trend it is not durable. Retaining almost no earnings ($78.4M retained, essentially flat) while adding debt to buy back stock at 23x is aggressive capital allocation into a declining business.